Delivery Order SPE2DB20D1100-SPE2DB25FD8L3
- Not listed
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle designed to provide comprehensive pharmaceutical and medical supply support to military...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical supply chain, providing vaccines and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for M-M-R II vaccine vials with a ceiling value of $126,439.10. This firm fixed-price delivery order, which is a non-set-aside competitive award, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.76 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,294.08 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,711.00 to AmerisourceBergen Drug Corp for MMR II vaccine vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been...
- The Defense Logistics Agency awarded a $2,351.28 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for M-M-R II vaccine vials, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, without a set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8L3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,616.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-set-aside contract issued on August 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this vaccine supply requirement as part of its extensive portfolio of pharmaceutical and medical supply deliveries to defense and military healthcare systems. The company's contract awards with DLA consistently involve delivery orders with firm fixed pricing for a diverse range of medical products, including specialty medications, vaccines, and medical supplies supporting the Defense Health Agency and other federal healthcare entities. This M-M-R II vaccine vial order represents routine replenishment activity under the established prime vendor relationship supporting military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 8/5/25 |